ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $37,756,000 | +33.2% | 2,766,008 | 0.0% | 0.95% | +4.5% |
Q4 2018 | $28,352,000 | -24.9% | 2,766,008 | +22.1% | 0.91% | -9.0% |
Q3 2018 | $37,729,000 | +5.4% | 2,266,008 | 0.0% | 1.00% | -3.5% |
Q2 2018 | $35,803,000 | +24.4% | 2,266,008 | 0.0% | 1.03% | +30.1% |
Q1 2018 | $28,778,000 | +10.9% | 2,266,008 | 0.0% | 0.80% | +8.8% |
Q4 2017 | $25,946,000 | -6.5% | 2,266,008 | 0.0% | 0.73% | -4.8% |
Q3 2017 | $27,759,000 | +24.9% | 2,266,008 | +16.7% | 0.77% | +13.1% |
Q2 2017 | $22,225,000 | -36.6% | 1,941,008 | +15.2% | 0.68% | -40.8% |
Q1 2017 | $35,051,000 | 0.0% | 1,685,150 | 0.0% | 1.15% | -11.6% |
Q4 2016 | $35,051,000 | -36.5% | 1,685,150 | 0.0% | 1.30% | -33.1% |
Q3 2016 | $55,222,000 | +31.2% | 1,685,150 | 0.0% | 1.94% | +16.9% |
Q2 2016 | $42,078,000 | +13.8% | 1,685,150 | +11.6% | 1.66% | +13.0% |
Q1 2016 | $36,984,000 | -25.9% | 1,510,150 | 0.0% | 1.47% | +4.6% |
Q4 2015 | $49,880,000 | +0.8% | 1,510,150 | 0.0% | 1.40% | -10.5% |
Q3 2015 | $49,473,000 | -19.1% | 1,510,150 | +30.7% | 1.57% | -5.4% |
Q2 2015 | $61,188,000 | – | 1,155,150 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |